SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001493152-17-014727
Filing Date
2017-12-18
Accepted
2017-12-18 17:05:26
Documents
11

Document Format Files

Seq Description Document Type Size
1 formf-3.htm F-3 684266
2 ex4-9.htm EX-4.9 895019
3 ex5-1.htm EX-5.1 28427
4 ex5-2.htm EX-5.2 23173
5 ex23-3.htm EX-23.3 4628
6 f3_001.jpg GRAPHIC 3090
7 f-3_001.jpg GRAPHIC 3477
8 image_001.jpg GRAPHIC 8063
9 image_003.jpg GRAPHIC 10456
10 image_002.jpg GRAPHIC 2387
11 ex23-3_001.jpg GRAPHIC 15117
  Complete submission text file 0001493152-17-014727.txt   1695809
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-222138 | Film No.: 171262090
SIC: 2834 Pharmaceutical Preparations